News & Events
9/21/23
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
9/12/23
QuidelOrtho Appoints Juliet Cunningham As Vice President Of Investor Relations
8/28/23
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
8/8/23
QuidelOrtho Reports Second Quarter 2023 Financial Results
7/25/23
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
7/24/23
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
7/18/23
QuidelOrtho to Report Second Quarter 2023 Financial Results
5/23/23
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
5/8/23
QuidelOrtho Receives FDA De Novo Classification for two Sars-Cov-2 Antibody tests: Vitros® Immunodiagnostic Products Anti-Sars-Cov-2 Total Test and Vitros® Immunodiagnostic Products Anti-Sars-Cov-2 IgG Test
5/3/23
QuidelOrtho Reports First Quarter 2023 Financial Results
4/13/23
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023
3/29/23
Celebrate and be inspired — Lab Week 2023 Keynote webinar available now
3/28/23
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
3/8/23
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
3/2/23
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
2/15/23
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results
1/06/23
QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
12/29/22
QuidelOrtho to Present at the J.P. Morgan Healthcare Conference
12/27/22
Jets Partnered With QuidelOrtho and American Red Cross to Host Holiday Blood Drive
12/19/22
Health Canada Grants License for Quidel® TriageTrue® High-Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction
11/02/22
QuidelOrtho Reports Third Quarter 2022 Financial Results
12/12/22
QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles
12/01/22
QuidelOrtho to Host Investor Day on December 13, 2022
11/02/22
QuidelOrtho Reports Third Quarter 2022 Financial Results
10/12/22
QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022
09/06/22
QuidelOrtho to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
09/01/22
Quidel and World Champion Los Angeles Rams Partner to Combat COVID-19 and Promote Health Awareness in the L.A. Community
08/18/22
QuidelOrtho Announces $300 Million Share Repurpose Authorization
08/16/22
QuidelOrtho Joins Alliance for a Strong Blood Supply Launched by Association for the Advancement of Blood & Biotherapies
08/10/22
Podcast: QuidelOrtho provides easier, faster test results with new molecular platform
08/05/22
QuidelOrtho Reports Second Quarter 2022 Financial Results
07/26/22
Ortho Ranks No. 1 in Customer Satisfaction for 5 Years in a Row (prnewswire.com)
07/19/22
Quidel Named First Partner at SDSU Mission Valley Innovation District, Founding Partner at Snapdragon Stadium
07/12/22
Quidel Corporation and the American Heart Association join forces to advance education and awareness of heart disease in San Diego County
06/07/22
Here’s How San Diego Biotech Helped Fight The COVID-19 Pandemic
05/27/22
QuidelOrtho Formed by the Completion of Quidel’s Acquisition of Ortho Clinical Diagnostics
05/26/22
Quidel and Ortho Announce Expected Closing of Ortho Transaction
05/16/22
Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination
05/08/22
Quidel Corporation and Ortho Clinical Diagnostics to exhibit at the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo
05/04/22
Quidel Reports First Quarter 2022 Financial Results
05/01/22
How Quidel Navigated COVID-19: A conversation with Quidel President and CEO Doug Bryant
12/23/21
Quidel Corporate Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
